BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22238406)

  • 1. Symptomatic heterozygotes and prenatal diagnoses in a nonconsanguineous family with syndromic combined pituitary hormone deficiency resulting from two novel LHX3 mutations.
    Sobrier ML; Brachet C; Vié-Luton MP; Perez C; Copin B; Legendre M; Heinrichs C; Amselem S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E503-9. PubMed ID: 22238406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation.
    Pfaeffle RW; Savage JJ; Hunter CS; Palme C; Ahlmann M; Kumar P; Bellone J; Schoenau E; Korsch E; Brämswig JH; Stobbe HM; Blum WF; Rhodes SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1909-19. PubMed ID: 17327381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss.
    Ramzan K; Bin-Abbas B; Al-Jomaa L; Allam R; Al-Owain M; Imtiaz F
    BMC Endocr Disord; 2017 Mar; 17(1):17. PubMed ID: 28302169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of LHX3 and PROP-1 in pituitary hormone deficiency patients with posterior pituitary ectopia.
    Sloop KW; Walvoord EC; Showalter AD; Pescovitz OH; Rhodes SJ
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2701-8. PubMed ID: 10946868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.
    de Graaff LC; Argente J; Veenma DC; Drent ML; Uitterlinden AG; Hokken-Koelega AC
    Horm Res Paediatr; 2010; 73(5):363-71. PubMed ID: 20389107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency.
    Bhangoo AP; Hunter CS; Savage JJ; Anhalt H; Pavlakis S; Walvoord EC; Ten S; Rhodes SJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):747-53. PubMed ID: 16394081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations.
    Kriström B; Zdunek AM; Rydh A; Jonsson H; Sehlin P; Escher SA
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1154-61. PubMed ID: 19126629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency.
    Bechtold-Dalla Pozza S; Hiedl S; Roeb J; Lohse P; Malik RE; Park S; Durán-Prado M; Rhodes SJ
    Horm Res Paediatr; 2012; 77(1):41-51. PubMed ID: 22286346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature.
    Bonfig W; Krude H; Schmidt H
    Eur J Pediatr; 2011 Aug; 170(8):1017-21. PubMed ID: 21249393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.
    Baş F; Uyguner ZO; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Şiklar Z; Öcal G; Darcan Ş; Gökşen D; Topaloğlu AK; Yüksel B; Özbek MN; Ercan O; Evliyaoğlu O; Çetinkaya S; Şen Y; Atabek E; Toksoy G; Aydin BK; Bundak R
    Endocrine; 2015 Jun; 49(2):479-91. PubMed ID: 25500790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous LHX3 mutations may lead to a mild phenotype of combined pituitary hormone deficiency.
    Jullien N; Romanet P; Philippon M; Quentien MH; Beck-Peccoz P; Bergada I; Odent S; Reynaud R; Barlier A; Saveanu A; Brue T; Castinetti F
    Eur J Hum Genet; 2019 Feb; 27(2):216-225. PubMed ID: 30262920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients.
    Reynaud R; Gueydan M; Saveanu A; Vallette-Kasic S; Enjalbert A; Brue T; Barlier A
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3329-36. PubMed ID: 16735499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development.
    Sobrier ML; Attié-Bitach T; Netchine I; Encha-Razavi F; Vekemans M; Amselem S
    Gene Expr Patterns; 2004 Dec; 5(2):279-84. PubMed ID: 15567726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LHX3 and LHX4 transcription factors in pituitary development and disease.
    Colvin SC; Mullen RD; Pfaeffle RW; Rhodes SJ
    Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():283-90. PubMed ID: 19337183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency.
    Netchine I; Sobrier ML; Krude H; Schnabel D; Maghnie M; Marcos E; Duriez B; Cacheux V; Moers Av; Goossens M; Grüters A; Amselem S
    Nat Genet; 2000 Jun; 25(2):182-6. PubMed ID: 10835633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of brazilian patients with combined pituitary hormone deficiency and orthotopic posterior pituitary lobe reveals eight different PROP1 alterations with three novel mutations.
    Madeira JL; Nishi MY; Nakaguma M; Benedetti AF; Biscotto IP; Fernandes T; Pequeno T; Figueiredo T; Franca MM; Correa FA; Otto AP; Abrão M; Miras MB; Santos S; Jorge AA; Costalonga EF; Mendonca BB; Arnhold IJ; Carvalho LR
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):725-732. PubMed ID: 28734020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of LHX4 Mutations to Pituitary Deficits in a Cohort of 417 Unrelated Patients.
    Cohen E; Maghnie M; Collot N; Leger J; Dastot F; Polak M; Rose S; Touraine P; Duquesnoy P; Tauber M; Copin B; Bertrand AM; Brioude F; Larizza D; Edouard T; González Briceño L; Netchine I; Oliver-Petit I; Sobrier ML; Amselem S; Legendre M
    J Clin Endocrinol Metab; 2017 Jan; 102(1):290-301. PubMed ID: 27820671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.
    Rainbow LA; Rees SA; Shaikh MG; Shaw NJ; Cole T; Barrett TG; Kirk JM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):163-8. PubMed ID: 15670191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion.
    Dateki S; Fukami M; Uematsu A; Kaji M; Iso M; Ono M; Mizota M; Yokoya S; Motomura K; Kinoshita E; Moriuchi H; Ogata T
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4043-7. PubMed ID: 20534763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.
    Vieira TC; Boldarine VT; Abucham J
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1097-103. PubMed ID: 18157385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.